Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-184

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health opportunity PAR-25-184

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-184Grants.gov
Related Grants
Health● Open
DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Varies
14 Oct 2026(12d)
Health● Open
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Varies
29 Jan 2029(850d)
Health● Open
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
Varies
07 May 2027(217d)
Health● Open
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Varies
12 Mar 2029(892d)
Funding Amount
Varies
USD
Application Deadline
15 October 2027
378 days remaining
Opens: 26 Nov 2024
Apply Now
Programme Details
Programme Code
PAR-25-184